0001705381-26-000006.txt : 20260709 0001705381-26-000006.hdr.sgml : 20260709 20260709153009 ACCESSION NUMBER: 0001705381-26-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260709 DATE AS OF CHANGE: 20260709 EFFECTIVENESS DATE: 20260709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CeleCor Therapeutics, Inc. CENTRAL INDEX KEY: 0001705381 ORGANIZATION NAME: EIN: 870723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590216 FILM NUMBER: 261165548 BUSINESS ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-777-9750 MAIL ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0708 D LIVE 0001705381 CeleCor Therapeutics, Inc. 1155 CAMINO DEL MAR SUITE 481 DEL MAR CA CALIFORNIA 92014 858-777-9750 DELAWARE None None Corporation true Robert S. Hillman, Ph.D. 1155 Camino Del Mar Del Mar CA CALIFORNIA 92014 Executive Officer Director Andreas Ritzi 1155 Camino Del Mar Del Mar CA CALIFORNIA 92014 Director Jack Lief 1155 Camino Del Mar Del Mar CA CALIFORNIA 92014 Director Peter B. Finn 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer Secretary Pharmaceuticals Decline to Disclose 06b false 2026-06-09 false true false 0 15000000 11856325 3143675 false 17 0 0 0 false CeleCor Therapeutics, Inc. Peter B. Finn Peter B. Finn Secretary 2026-07-09